arrow
F

Francesco Bruno

University of Florence
H指数:17
被引数:968

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Age at natural menopause; reproductive lifespan and Alzheimer’s disease in females: is APOE ε4 the missing link?

自然绝经年龄;女性生育寿命与阿尔茨海默病:APOE ε4是否是缺失的关键环节?

2026-03-110
OAAI
The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk

与冠状动脉疾病相关的连接蛋白可预测高残余风险急性冠状动脉综合征患者的不良心血管事件。

2025-12-010
OAAI
Safety and efficacy of P2Y12 inhibitors in acute coronary syndromes patients with KDIGO stage IV-V renal disfunction not on dialysis: a subanalysis of the CORALYS registry

P2Y12抑制剂在未接受透析的KDIGO IV-V期肾功能不全急性冠状动脉综合征患者中的安全性与有效性:CORALYS注册研究的亚组分析

2025-07-130
PRE
Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: design and rationale of the STEMI-Cool study (vol 282, pg 40, 2025)

经冠状动脉冷却和稀释以在ST段抬高型心肌梗死再血管化过程中提供心脏保护:STEMI-Cool研究的设计与原理(卷282,页40,2025)

2025-06-040
PRE
Genetic variability in ADAM17/TACE is associated with sporadic Alzheimer's disease risk, neuropsychiatric symptoms and cognitive performance on the Rey Auditory Verbal Learning and Clock Drawing Tests

ADAM17/TACE的遗传变异与散发性阿尔茨海默病风险、神经精神症状以及Rey听觉言语学习测试和钟表绘制测试的认知表现相关。

2025-05-060
OA
Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: Design and rationale of the STEMI-Cool study
2025-04-010
PRE
Clinical impact of CCT-FFR as first-strategy in patients with symptomatic stable coronary artery disease: A systematic review and meta-analysis

作为初始策略时CCT-FFR对有症状稳定型冠状动脉疾病患者的临床影响:一项系统评价和荟萃分析

2025-03-010
PRE